World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
69
Citations
17641
World Ranking
7357
National Ranking
3366

Ralph B. Arlinghaus publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Ralph B. Arlinghaus sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 322 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Ralph B. Arlinghaus D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ralph B. Arlinghaus sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 69 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Ralph B. Arlinghaus was affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their scientific career was linked to this institution, reflecting a focus that likely involved research and clinical activities within its scope.

No specific records of recent papers, co-authors, or publication venues were identified for this scientist. Similarly, there are no documented book publications, main fields or subfields of study, nor main topics of work associated with their profile.

There were no available awards or recognitions documented for Ralph B. Arlinghaus. The absence of such data implies that publicly accessible records do not detail any formal honors or distinctions.

Given that the scientist is deceased, references to their work are presented in past tense. The lack of available detailed publication data and other research metrics limits the extent of profiling possible, though the connection to The University of Texas MD Anderson Cancer Center suggests an involvement in biomedical or cancer-related research during their active career.

Best Publications

  • BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

    Nicholas J. Donato;Ji Yuan Wu;Jonathan Stapley;Gary Gallick

  • Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53

    Hiroshi Katayama;Kaori Sasai;Hidehiko Kawai;Hidehiko Kawai;Zhi Min Yuan

  • Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.

    Lorri Puil;Jiaxin Liu;Gerald Gish;Geraldine Mbamalu

  • Tissue-resident stem cells promote breast cancer growth and metastasis

    Fabian L. Muehlberg;Yao Hua Song;Alexander Krohn;Severin P. Pinilla

  • Radiation-induced Assembly of Rad51 and Rad52 Recombination Complex Requires ATM and c-Abl

    Gang Chen;Shyng Shiou F. Yuan;Wei Liu;Yang Xu

  • AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has In vitro Activity against Imatinib-Resistant Chronic Myeloid Leukemia

    Mirna Golemovic;Srdan Verstovsek;Francis Giles;Jorge Cortes

  • Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia.

    Nicholas J. Donato;Ji Y. Wu;Jonathan Stapley;Hui Lin

  • TYROSINE PHOSPHORYLATION OF CRKL IN PHILADELPHIA+ LEUKEMIA

    J ten Hoeve;RB Arlinghaus;JQ Guo;N Heisterkamp

  • Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).

    Miloslav Beran;Xiaobo Cao;Zeev Estrov;Sima Jeha

  • Janus Kinase 2: A Critical Target in Chronic Myelogenous Leukemia

    Ajoy K. Samanta;Hui Lin;Tong Sun;Hagop M Kantarjian

  • PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells

    Paolo Neviani;Jason G. Harb;Joshua J. Oaks;Ramasamy Santhanam

  • Further characterization of intracellular precursor polyproteins of Rauscher leukemia virus.

    G.A. Jamjoom;R.B. Naso;R.B. Arlinghaus

  • Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis

    Xiaohong Leng;Tian Ding;Hui Lin;Yan Wang

  • Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia

    Hagop M. Kantarjian;Susan O'Brien;Jorge E. Cortes;Sergio A. Giralt

  • Multiplexed volumetric bar-chart chip for point-of-care diagnostics

    Yujun Song;Yuanqing Zhang;Paul E. Bernard;James M. Reuben

  • Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: High incidence of early complete and major cytogenetic responses

    Hagop M. Kantarjian;Jorge E. Cortes;Jorge E. Cortes;Susan O'Brien;Susan O'Brien;Francis Giles;Francis Giles

  • Jak2 is involved in c-Myc induction by Bcr-Abl.

    Shanhai Xie;Hui Lin;Tong Sun;Ralph B Arlinghaus

  • Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides.

    L.J. Arcement;W.L. Karshin;R.B. Naso;G. Jamjoom

  • Biosynthesis of Rauscher leukemia viral proteins

    Robert B. Naso;Larry J. Arcement;Ralph B. Arlinghaus

  • Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.

    Lei Wang;Lindsay Duke;Peter S. Zhang;Ralph B. Arlinghaus

Frequent Co-Authors

Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Moshe Talpaz
Moshe Talpaz University of Michigan–Ann Arbor
Jorge E. Cortes
Jorge E. Cortes Augusta University
Francis J. Giles
Francis J. Giles Northwestern University
Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Michael Andreeff
Michael Andreeff The University of Texas MD Anderson Cancer Center
Gary E. Gallick
Gary E. Gallick The University of Texas MD Anderson Cancer Center
Haifa Shen
Haifa Shen Houston Methodist
Albert B. Deisseroth
Albert B. Deisseroth US Food and Drug Administration
John W. Belmont
John W. Belmont Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Ralph B. Arlinghaus

Recently Published Articles